Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Inogen Inc Director's Dealing 2014

Apr 3, 2014

33625_dirs_2014-04-02_605e0ea0-0e2e-4437-91a4-cbaaf687a0a9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2014-04-01

Reporting Person: McFarland Loren L (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-04-01 Stock Option (Right to Buy) $16.62 A 13333 Acquired 2024-04-01 Common Stock (13333) Direct

Footnotes

F1: Subject to the reporting person's continuing service, 1/24th of the total shares subject to the option shall vest every month after April 1, 2014.